Ongoing Studies (No Longer Enrolling)

1. Sention Therapeutics

A Multicenter, Randomized, Double-Blind, Crossover, Phase 2 Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy with ST-1891 Compared to Levothyroxine in Patients with Primary Hypothyroidism

2. Eli Lilly & Co. I8H-MC-BDCX

A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults with Type 2 Diabetes

3. Eli Lilly & Co. I8F-MC-GPGN

The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT)